000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥24.22
arrow_upward
+1.72%(+0.41) 1H
16 Okt, 11:33:48 PG GMT+8 · CNY
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 000739...
Buka
CN¥24.04
Tinggi
CN¥24.76
Rendah
CN¥23.83
Permodalan Pasaran
28.68B
Purata volum
16.27J
Volum
7.75J
Dividen
1.56%
Dividen suku tahunan
CN¥0.09
Tarikh tanpa dividen
8 Okt 2026
Nisbah H/P
32.87
tgi 52 mgu
CN¥28.50
rdh 52 mgu
CN¥14.89
EPS
CN¥0.74
Syer tertunggak
1.16B
Bilangan pekerja
7K
Buka
CN¥24.04
Tinggi
CN¥24.76
Rendah
CN¥23.83
Permodalan Pasaran
28.68B
Purata volum
16.27J
Volum
7.75J
Dividen
1.56%
Dividen suku tahunan
CN¥0.09
Tarikh tanpa dividen
8 Okt 2026
Nisbah H/P
32.87
tgi 52 mgu
CN¥28.50
rdh 52 mgu
CN¥14.89
EPS
CN¥0.74
Syer tertunggak
1.16B
Bilangan pekerja
7K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Astro Awani
·
1 hari lalu
S&P 500: Wall Street market update | 15 October 2026
Invezz
·
3 hari lalu
Dow naik 198 mata, saham AS bercampur menjelang keputusan pendapatan
Invezz
·
2 hari lalu
Dow ditutup 170 mata lebih rendah ketika penjualan saham cip berterusan
Investing.com
·
28 minit lalu
Dow jumps 556 pts while Nvidia keeps bleeding, our AI spotted the pivot weeks ago
Profil
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Perihal Apeloa Pharmaceutical Co Ltd